Envelope proteins of spleen necrosis virus form infectious human immunodeficiency virus type 1 pseudotype vector particles, but fail to incorporate upon substitution of the cytoplasmic domain with that of Gibbon ape leukemia virus

References

1. Bobkova M., Stitz J., Engelstadter M., Cichutek K., Buchholz C. J. 2002; Identification of R-peptides in envelope proteins of C-type retroviruses. J Gen Virol 83:2241–2246
   [Google Scholar]
2. Christodoulopoulos I., Cannon P. M. 2001; Sequences in the cytoplasmic tail of the gibbon ape leukemia virus envelope protein that prevent its incorporation into lentivirus vectors. J Virol 75:4129–4138 [CrossRef]
   [Google Scholar]
3. Cui Z. Z., Lee L. F., Silva R. F., Witter R. L. 1986; Monoclonal antibodies against avian reticuloendotheliosis virus: identification of strain-specific and strain-common epitopes. J Immunol 136:4237–4242
   [Google Scholar]
4. Engelstadter M., Bobkova M., Baier M. & 7 other authors 2000; Targeting human T cells by retroviral vectors displaying antibody domains selected from a phage display library. Hum Gene Ther 11:293–303 [CrossRef]
   [Google Scholar]
5. Engelstadter M., Buchholz C. J., Bobkova M., Steidl S., Merget-Millitzer H., Willemsen R. A., Stitz J., Cichutek K. 2001; Targeted gene transfer to lymphocytes using murine leukaemia virus vectors pseudotyped with spleen necrosis virus envelope proteins. Gene Ther 8:1202–1206 [CrossRef]
   [Google Scholar]
6. Green N., Shinnick T. M., Witte O., Ponticelli A., Sutcliffe J. G., Lerner R. A. 1981; Sequence-specific antibodies show that maturation of Moloney leukemia virus envelope polyprotein involves removal of a COOH-terminal peptide. Proc Natl Acad Sci U S A 78:6023–6027 [CrossRef]
   [Google Scholar]
7. Henderson L. E., Sowder R., Copeland T. D., Smythers G., Oroszlan S. 1984; Quantitative separation of murine leukemia virus proteins by reversed-phase high-pressure liquid chromatography reveals newly described gag and env cleavage products. J Virol 52:492–500
   [Google Scholar]
8. Jiang A., Chu T.-H. T., Nocken F., Cichutek K., Dornburg R. 1998; Cell-type-specific gene transfer into human cells with retroviral vectors that display single-chain antibodies. J Virol 72:10148–10156
   [Google Scholar]
9. Kiernan R. E., Freed E. O. 1998; Cleavage of the murine leukemia virus transmembrane env protein by human immunodeficiency virus type 1 protease: transdominant inhibition by matrix mutations. J Virol 72:9621–9627
   [Google Scholar]
10. Leurs C., Jansen M., Pollok K. E. & 8 other authors 2003; Comparison of three retroviral vector systems for transduction of nonobese diabetic/severe combined immunodeficiency mice repopulating human CD34⁺ cord blood cells. Hum Gene Ther 14:509–519 [CrossRef]
    [Google Scholar]
11. Merten C. A., Stitz J., Braun G., Poeschla E. M., Cichutek K., Buchholz C. J. 2005; Directed evolution of retrovirus envelope protein cytoplasmic tails guided by functional incorporation into lentivirus particles. J Virol 79:834–840 [CrossRef]
    [Google Scholar]
12. Miyoshi H., Smith K. A., Moiser D. E., Verma I. M., Torbett B. E. 1999; Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science 283:682–686 [CrossRef]
    [Google Scholar]
13. Muhlebach M. D., Schmitt I., Steidl S., Stitz J., Schweizer M., Blankenstein T., Cichutek K., Uckert W. 2003; Transduction efficiency of MLV but not HIV-1 vectors is pseudotype dependent on human primary T lymphocytes. J Mol Med 81:801–810 [CrossRef]
    [Google Scholar]
14. Naldini L., Blomer U., Gallay P., Ory D., Mulligan R., Gage F. H., Verma I. M., Trono D. 1996; In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263–267 [CrossRef]
    [Google Scholar]
15. Rein A., Mirro J., Haynes J. G., Ernst S. M., Nagashima K. 1994; Function of the cytoplasmic domain of a retroviral transmembrane protein: p15-p2E cleavage activates the membrane fusion capability of the murine leukemia virus Env protein. J Virol 68:1773–1781
    [Google Scholar]
16. Relander T., Johansson M., Olsson K., Ikeda Y., Takeuchi Y., Collins M., Richter J. 2005; Gene transfer to repopulating human CD34+ cells using amphotropic-, GaLV-, or RD114-pseudotyped HIV-1-based vectors from stable producer cells. Mol Ther 11:452–459 [CrossRef]
    [Google Scholar]
17. Sandrin V., Muriaux D., Darlix J. L., Cosset F. L. 2004; Intracellular trafficking of Gag and Env proteins and their interactions modulate pseudotyping of retroviruses. J Virol 78:7153–7164 [CrossRef]
    [Google Scholar]
18. Soneoka Y., Cannon P. M., Ramsdale E. E., Griffiths J. C., Romano G., Kingsman S. M., Kingsman A. J. 1995; A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res 23:628–633 [CrossRef]
    [Google Scholar]
19. Stitz J., Buchholz C. J., Engelstadter M., Uckert W., Bloemer U., Schmitt I., Cichutek K. 2000; Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1. Virology 273:16–20 [CrossRef]
    [Google Scholar]
20. Zhao Y., Zhu L., Benedict C. A., Chen D., Anderson W. F., Cannon P. M. 1998; Functional domains in the retroviral transmembrane protein. J Virol 72:5392–5398
    [Google Scholar]